PL3491139T3 - Wektory lentiwirusowe do ekspresji antygenów wirusa zapalenia wątroby typu B (HBV) - Google Patents
Wektory lentiwirusowe do ekspresji antygenów wirusa zapalenia wątroby typu B (HBV)Info
- Publication number
- PL3491139T3 PL3491139T3 PL17749145.3T PL17749145T PL3491139T3 PL 3491139 T3 PL3491139 T3 PL 3491139T3 PL 17749145 T PL17749145 T PL 17749145T PL 3491139 T3 PL3491139 T3 PL 3491139T3
- Authority
- PL
- Poland
- Prior art keywords
- hbv
- hepatitis
- antigens
- virus
- expression
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16305976.9A EP3276006A1 (en) | 2016-07-27 | 2016-07-27 | Lentiviral vectors for expression of hepatitis b virus (hbv) antigens |
| PCT/EP2017/068412 WO2018019705A1 (en) | 2016-07-27 | 2017-07-20 | Lentiviral vectors for expression of hepatitis b virus (hbv) antigens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3491139T3 true PL3491139T3 (pl) | 2022-08-16 |
Family
ID=56939982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17749145.3T PL3491139T3 (pl) | 2016-07-27 | 2017-07-20 | Wektory lentiwirusowe do ekspresji antygenów wirusa zapalenia wątroby typu B (HBV) |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10864265B2 (pl) |
| EP (2) | EP3276006A1 (pl) |
| CN (1) | CN109923212B (pl) |
| DK (1) | DK3491139T3 (pl) |
| ES (1) | ES2914238T3 (pl) |
| PL (1) | PL3491139T3 (pl) |
| PT (1) | PT3491139T (pl) |
| WO (1) | WO2018019705A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114107393A (zh) | 2021-04-07 | 2022-03-01 | 上海劲威生物科技有限公司 | 一种治疗乙型肝炎的慢病毒载体、慢病毒颗粒及其制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1076715E (pt) * | 1998-05-13 | 2007-10-26 | Genetix Pharmaceuticals Inc | Células empacotadoras lentivirais |
| DK1092779T3 (da) | 1999-10-11 | 2010-02-15 | Pasteur Institut | Lentiviirusvektorer til fremstilling af immunterapeutiske præparater |
| WO2008103380A2 (en) * | 2007-02-21 | 2008-08-28 | Fox Chase Cancer Center | Hepatitis b virus compositions and methods of use |
| JP5897464B2 (ja) * | 2009-08-07 | 2016-03-30 | トランジェーヌ、ソシエテ、アノニムＴｒａｎｓｇｅｎｅ Ｓ．Ａ． | Ｈｂｖ感染を治療するための組成物 |
| CN102038948B (zh) * | 2009-10-10 | 2013-04-10 | 复旦大学 | 一种控制乙型肝炎病毒持续性感染的疫苗 |
| EP2666477A1 (en) * | 2012-05-23 | 2013-11-27 | Theravectys | Lentiviral vectors containing an MHC class I promoter |
| EP2672991B1 (en) * | 2011-02-12 | 2017-07-19 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis b infection |
| AU2015259470A1 (en) * | 2014-05-16 | 2016-11-10 | Yale University | Virus like vesicles (VLVs) based vaccines to prevent or treat chronic hepatitis B virus (HBV) infection |
| WO2016120492A1 (en) * | 2015-02-01 | 2016-08-04 | Theravectys | Lentiviral vectors for expression of hepatitis b virus (hbv) antigens |
-
2016
- 2016-07-27 EP EP16305976.9A patent/EP3276006A1/en not_active Withdrawn
-
2017
- 2017-07-20 EP EP17749145.3A patent/EP3491139B1/en active Active
- 2017-07-20 US US16/320,772 patent/US10864265B2/en active Active
- 2017-07-20 DK DK17749145.3T patent/DK3491139T3/da active
- 2017-07-20 ES ES17749145T patent/ES2914238T3/es active Active
- 2017-07-20 PL PL17749145.3T patent/PL3491139T3/pl unknown
- 2017-07-20 PT PT177491453T patent/PT3491139T/pt unknown
- 2017-07-20 CN CN201780046919.6A patent/CN109923212B/zh active Active
- 2017-07-20 WO PCT/EP2017/068412 patent/WO2018019705A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN109923212B (zh) | 2023-06-06 |
| PT3491139T (pt) | 2022-06-20 |
| EP3491139A1 (en) | 2019-06-05 |
| EP3276006A1 (en) | 2018-01-31 |
| US10864265B2 (en) | 2020-12-15 |
| EP3491139B1 (en) | 2022-04-06 |
| WO2018019705A1 (en) | 2018-02-01 |
| US20190160166A1 (en) | 2019-05-30 |
| DK3491139T3 (da) | 2022-06-27 |
| CN109923212A (zh) | 2019-06-21 |
| ES2914238T3 (es) | 2022-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL264575A (en) | RNA materials for hepatitis b virus infection | |
| IL280459A (en) | Phosphoramidates for the treatment of hepatitis B virus | |
| HK1255847A1 (zh) | 針對乙型肝炎病毒的疫苗 | |
| HK1255502A1 (zh) | B型肝炎病毒(hbv)irna組合物及其使用方法 | |
| ZA201806651B (en) | Elimination of hepatitis b virus with antiviral agents | |
| ZA201900156B (en) | Phosphoramidates for the treatment of hepatitis b virus | |
| HK1248681A1 (zh) | 作為hbsag(hbv表面抗原)和hbv dna生成的抑制劑用於治療乙型肝炎病毒感染的四氫吡啶並嘧啶和四氫吡啶並吡啶類化合物 | |
| EP3439696A4 (en) | THERAPEUTIC VACCINE AGAINST THE HEPATITIS B VIRUS (HBV) USING THE HBV CORE ANTIGEN | |
| IL275427A (en) | Hepatitis virus vaccines HBV) B) and their uses | |
| EP3148566C0 (en) | SYNTHETIC LONG PEPTIDES (SLP) FOR THERAPEUTIC VACCINATION AGAINST HEPATITIS B VIRUS INFECTION | |
| HK1249046A1 (zh) | 治療b型肝炎病毒的方法 | |
| HK1251010A1 (zh) | 用於治療乙型肝炎病毒(hbv)感染的試劑及用途 | |
| SI3137078T1 (sl) | Zdravljenje okužbe s hepatitis delta virusom | |
| PT3491139T (pt) | Vetores lentivirais para expressão de antigénios de vírus da hepatite b (hbv) | |
| IL286484B (en) | Reagents for treatment of hepatitis b virus (hbv) infection and use thereof | |
| GB201702193D0 (en) | Hepatitis E virus vaccine |